Physician profile
George Richard
NPI 1073046231
$34,270.97
in general payments reported to CMS, 2019-2025
20 companies · $2,348 in 2025
The $2,348 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,613 · 2022: $26K · 2023: $3,990 · 2024: $707 · 2025: $2,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,056 · Food and Beverage: $2,440 · Travel and Lodging: $1,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,055.83 |
| Food and Beverage | $2,439.67 |
| Travel and Lodging | $1,549.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $23,583.00 | 2021-2025 | Shoulder Implants Biceps Repair Fibertak, Shoulder Implants Fibertak Knotless |
| Smith+Nephew, INC. | $6,747.44 | 2022-2025 | Bone Anchors With Arthroscopic Delivery System, Healicoil, Q-Fix |
| Prime Surgical, LLC | $1,213.93 | 2022-2023 | |
| Cgg Medical INC | $1,200.00 | 2022 | |
| Miach Orthopaedics, INC. | $392.78 | 2023-2025 | |
| Stryker Corporation | $182.05 | 2023-2024 | Inspace, T2 |
| Vericel Corporation | $154.60 | 2024 | Maci |
| Si-Bone, INC. | $105.03 | 2022 | |
| Reel Surgical, INC. | $104.74 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $86.07 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $82.09 | 2024-2025 | Exparel, Iovera, Zilretta |
| Ferring Pharmaceuticals INC. | $78.51 | 2024-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $75.58 | 2023 | Dynacord, Truespan Orthocord, Healix Knotless Peek |
| Linvatec Corporation | $65.30 | 2024 | Biobrace 23mm |
| Next Science LLC | $59.48 | 2025 | Xperience, Blastx |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $52.18 | 2022 | |
| Averitas Pharma INC. | $28.71 | 2024 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $25.94 | 2025 | |
| Heron Therapeutics, INC. | $17.03 | 2023 | Zynrelef |
| Curonix LLC | $16.51 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Richard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.